Structure Therapeutics Announces Participation in Upcoming Investor Conferences
26 Agosto 2024 - 3:05PM
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global
biopharmaceutical company developing novel oral small molecule
therapeutics for metabolic and cardiopulmonary diseases, today
announced management will participate at the following investor
conferences in September:
- Morgan Stanley 22nd Annual Global Healthcare ConferenceFireside
chat: Thursday, September 5 at 10:00 a.m. EDT
- Cantor Fitzgerald Global Healthcare Conference 2024Fireside
chat: Thursday, September 19 at 9:10 a.m. EDT
Live and archived webcasts of the fireside chats will be
accessible from the company’s website
https://ir.structuretx.com/events-presentations/events. Replays of
the webcasts will be available for 90 days.
About Structure TherapeuticsStructure
Therapeutics is a science-driven clinical-stage biopharmaceutical
company focused on discovering and developing innovative oral small
molecule treatments for chronic metabolic and cardiopulmonary
conditions with significant unmet medical needs. Utilizing its next
generation structure-based drug discovery platform, the Company has
established a robust GPCR-targeted pipeline, featuring multiple
wholly-owned proprietary clinical-stage small molecule compounds
designed to surpass the scalability limitations of traditional
biologic and peptide therapies and be accessible to more patients
around the world. For additional information, please visit
www.structuretx.com.
Investors:Danielle KeatleyStructure
Therapeutics Inc.ir@structuretx.com
Media:Dan Budwick1ABDan@1abmedia.com
Structure Therapeutics (NASDAQ:GPCR)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Structure Therapeutics (NASDAQ:GPCR)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024